Market Dynamics and Competitive Strategies: Insights into the Anti-Vascular Endothelial Growth Factor Therapeutics Market
The Anti-Vascular Endothelial Growth Factor (Anti-VEGF) therapeutics market continues to evolve as demand rises for advanced biologics and targeted treatments addressing diseases driven by abnormal blood vessel formation. These therapies, which inhibit angiogenesis, have become cornerstones in the management of cancer and ocular disorders such as age-related macular degeneration (AMD) and...
0 Commentarios 0 Acciones 216 Views 0 Vista previa